Back to Search Start Over

Frontline Treatment with Zanubrutinib Plus Rituximab (ZR) Followed By Short Course R-Dhaox Shows Potent Efficacy in Patients with Mantle Cell Lymphoma (MCL) - Preliminary Results of Phase II CHESS Clinical Trial

Authors :
Cai, Qingqing
Xia, Yi
Liu, Panpan
Zhang, Yuchen
Huang, Huiqiang
Gao, Yan
Li, Guowei
Sun, Xiuhua
Pan, Xueyi
Source :
Blood; November 2022, Vol. 140 Issue: 1, Number 1 Supplement 1 p9356-9357, 2p
Publication Year :
2022

Details

Language :
English
ISSN :
00064971 and 15280020
Volume :
140
Issue :
1, Number 1 Supplement 1
Database :
Supplemental Index
Journal :
Blood
Publication Type :
Periodical
Accession number :
ejs62737663
Full Text :
https://doi.org/10.1182/blood-2022-166237